Annex
United Kingdom
In Table 1 of the Annex to Regulation (EU) No 37/2010, the entry for the substance ‘gamithromycin’ is replaced by the following:
Pharmacologically active Substance Marker residue Animal Species MRLs Target Tissues Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009) Therapeutic Classification ‘Gamithromycin Gamithromycin Porcine 100 μg/kg Muscle NO ENTRY Anti-infectious agents/Antibiotics’ 100 μg/kg Skin and fat in natural proportions 100 μg/kg Liver 300 μg/kg Kidney Bovine 20 μg/kg Fat Not for use in animals producing milk for human consumption. 200 μg/kg Liver 100 μg/kg Kidney